Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas

Gastroenterology

Volumn 123, Issue 4, 2002, Pages 1052-1060

  Kim, Grace E ^a,b   Bae, Han Ik ^a,c   Park, Hee Ug ^a,c   Kuan, Shih Fan ^d   Crawley, Suzanne C ^a,c   Ho, Jenny J L ^a,c   Kim, Young S ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 5AC; MUCIN 6; MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN; PROTEIN ND2; SIALYL TN ANTIGEN; STOMACH MUCIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CARCINOMA IN SITU; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; TISSUE SPECIFICITY;

EID: 0036788264     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.36018     Document Type: Article

References (54)

1. Kim YS, Gum J Jr, Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconj J 1996;13:693-707.
2. Kim YS, Gum JR Jr, Crawley SC, Deng G, Ho JJ. Mucin gene and antigen expression in biliopancreatic carcinogenesis. Ann Oncol 1999;10:S51-S55.
3. Itzkowitz S, Kjeldsen T, Friera A, Hakomori S, Yang U, Kim YS. Expression of Tn, sialyosyl Tn, and T antigens in human pancreas. Gastroenterology 1991;100:1691-1700.
4. Williams SJ, Wreschner DH, Tran M, Eyre HJ, Sutherland GR, McGuckin MA. MUC13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem 2001; 276:18327-18336.
5. Hendrix E, Hewetson A, Mansharamani M, Chilton BS. Oviductin (MUC9) is expressed in rabbit endocervix. Endocrinology 2001; 142:2151-2154.
6. Melnick M, Chen H, Zhou Y, Jaskoll T. An alternatively spliced Muc 10 glycoprotein ligand for putative L-selectin binding during mouse embryonic submandibular gland morphogenesis. Arch Oral Biol 2001;46:745-757.
7. Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Suterland GR, Antalis TM. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 1999;59: 4083-4089.
8. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993;53:641-651.
9. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989;52:257-331.
10. Springer GF, Desai PR, Ghazizadeh M, Tegtmeyer H. T/Tn pancarcinoma autoantigens: fundamental, diagnostic, and prognostic aspects. Cancer Detect Prev 1995;19:173-182.
11. Girling A, Bartkova J, Burchell J, Gendler S, Gillett C, Taylor-Papadimitriou J. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 1989;43:1072-1076.
12. Merlo GR, Siddiqui J, Cropp CS, Liscia DS, Lidereau R, Callahan R, Kufe DW. Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas. Cancer Res 1989;49:6966-6971.
13. x with MUC-1 apomucin in a pancreatic cancer cell line. Cancer Res 1995;55:3659-3663.
14. Kim YS, Itzkowitz SH, Yuan M, Chung Y, Satake K, Umeyama K, Hakomori S. Lex and Ley antigen expression in human pancreatic cancer. Cancer Res 1988;48:475-482.
15. Balagué C, Gambús G, Carrato C, Porchet N, Aubert JP, Kim YS, Real FX. Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreatic cancer cell lines and tissues. Gastroenterology 1994;106:1054-1061.
16. Balagué C, Audie JP, Porchet N, Real FX. In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. Gastroenterology 1995;109:953-964.
17. Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA, Buchler MW, Aubert JP, Batra SK. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res 2001;7:4033-4040.
18. Sommers SC, Murphy SA, Waren S. Pancreatic duct hyperplasia and cancer. Arch Pathol 1954;27:629-640
19. Cubilla AL, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976;36:2690-2698.
20. Kozuka S, Sassa R, Taki T, Masamoto K, Nagasawa S, Saga S, Hasegawa K, Takeuchi M. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979;43:1418-1428.
21. Klimstra DS, Longnecker DS. K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 1994;145:1547-1550.
22. DiGiuseppe JA, Hruban RH, Goodman SN, Polak M, vanden Berg FM, Allison DC, Cameron JL, Offerhaus GJA. Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994;101:684-688.
23. Day JD, DiGiuseppe JA, Yeo C, Loi-Goldman M, Anderson SM, Kern SE, Hruban RH. Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum Pathol 1996;27:119-124.
24. Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, Yoshida H, Machinami R, Kishi K, Omata M. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996;110:227-231.
25. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997;57:2140-2143.
26. Terhune PG, Phifer DM, Tosteson TD, Longnecker DS. K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev 1998;7:515-521.
27. Lüttges J, Schlehe B, Menke MA, Vogel I, Henne-Bruns D, KlÖppel G. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer 1999;85:1703-1710.
28. Wilentz RE, lacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, Kern SE, Hruban RH. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 2000; 60:2002-2006.
29. Goggins M, Hruban RH, Kern SE. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol 2000;156:1767-1771.
30. Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T. Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 2000;156:2123-2133.
31. Hruban RH, Goggins M, Parsons J, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res 2000;6:2969-2972.
32. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra DS, KlÖppel G, Longnecker DS, Lüttges J, Offerhaus GJA. Pancreatic intraepithelial neoplasia. A new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-586.
33. Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 1981;28:17-21.
34. Xing PX, Prenzoska J, Layton GT, Devine PL, McKenzie IF. Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer. J Natl Cancer Inst 1992;84:699-703.
35. Bara J, Gautier R, Mouradian P, Decanens C, Daher N. Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis. Int J Cancer 1991;47:304-310.
36. Bara J, Chastre E, Mahiou J, Singh RL, Forgue-Lafitte ME, Hollande E, Godeau F. Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int J Cancer 1998;75:767-773.
37. Reis CA, David L, Nielsen PA, Clausen H, Mirgorodskaya K, Roepstorff P, Sobrinho-Simoes M. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 1997;74:112-121.
38. Ho JJ, Bi N, Yan PS, Yuan M, Norton KA, Kim YS. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin. Cancer Res 1991;51:372-380.
39. Kjeldsen T, Clausen H, Hirohashi S, Ogawa T, lijima H, Hakomori S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res 1988;48: 2214-2220.
40. Tsuiji H, Hong JC, Kim YS, Ikehara Y, Narimatsu H, Irimura T. Novel carbohydrate specificity of monoclonal antibody 91.9H prepared against human colonic sulfomucin: recognition of sulfo-Lewisa structure. Biochem Biophys Res Commun 1998;253: 374-381.
41. Ho SB, Roberton AM, Shekels L, Lyftogt CT, Niehans GA, Toribara NW. Expression of cloning of gastric mucin complementary DNA and localization of mucin gene expression. Gastroenterology 1995;109:735-747.
42. Massimi M, Lear SR, Williams DL, Jones AL, Erickson SK. Differential expression of apolipoprotein E messenger RNA within the rat liver lobule determined by in situ hybridization. Hepatology 1999;29:1549-1555.
43. Audie JP, Janin A, Porchet N, Copin MC, Gosselin B, Aubert JP. Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. J Histochem Cytochem 1993;41:1479-1485.
44. de Bolós C, Garrido M, Real FX. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 1995;109: 723-734.
45. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 1990;265:15286-15293.
46. Ligtenberg MJL, Vos HL, Gennissen AMC, Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J Biol Chem 1990;265:5573-5578.
47. Lan MS, Batra SK, Qi WN, Metzgar RS, Hollingsworth MA. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem 1990;265:15294-15299.
48. Ho SB, Ewing SL, Montgomery CK, Kim YS. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence. Oncol Res 1996;8:53-61.
49. Buisine MP, Janin A, Maunoury V, Audie JP, Delescaut MP, Copin MC, Colombel JP, Degand P, Aubert JP, Porchet N. Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology 1996;110:84-91.
50. Bartman AE, Sanderson SJ, Ewing SL, Niehans GA, Wiehr CL, Evans MK, Ho SB. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer 1999;80: 210-218.
51. Klimstra DS. Pancreas. In: Stemberg SS, ed. Histology for pathologists. 2nd ed. Philadelphia: Lippincott-Raven, 1997; 635-638.
52. Osako M, Yonezawa S, Siddiki B, Huang J, Ho JJL, Kim YS, Sato E. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer 1993;71:2191-2199.
53. Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 1989;49:197-204.
54. Denk H, Tappeiner G, Davidovits A, Eckerstorfer R, Holzner JH. Carcinoembryonic antigen and blood group substances in carcinomas of the stomach and colon. J Natl Cancer Inst 1974;53: 933-942.